Publications by authors named "Mark Buchfuhrer"

Claim this Profile
T
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines.
Brian B Koo, J Andrew Berkowski, Mark Buchfuhrer

Expert Rev Neurother· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial.
Mark J Buchfuhrer, Asim Roy, Stephanye Rodriguez, Jonathan D Charlesworth

BMC Neurol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptoms.
Jonathan D Charlesworth, Bahman Adlou, Haramandeep Singh, Mark J Buchfuhrer

J Clin Sleep Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive neuromodulation reduces symptoms of restless legs syndrome.
Mark J Buchfuhrer, Fiona C Baker, Haramandeep Singh, Viktoriia Kolotovska, Bahman Adlou

J Clin Sleep Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Management of Restless Legs Syndrome: An Updated Algorithm.
Michael H Silber, Mark J Buchfuhrer, Christopher J Earley, Brian B Koo, Mauro Manconi

Mayo Clin Proc· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.
Denise Sharon, Richard P Allen, Pablo Martinez-Martin, Arthur S Walters, Luigi Ferini Strambi, Mark Buchfuhrer

Sleep Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome.
Michael H Silber, Philip M Becker, Mark J Buchfuhrer, Christopher J Earley, William G Ondo

Mayo Clin Proc· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
Neal Hermanowicz, Aaron Ellenbogen, Gordon Irving, Mark Buchfuhrer, Mark J Jaros

CNS Drugs· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Diego Garcia-Borreguero, Michael H Silber, John W Winkelman, Birgit Högl, Jacquelyn Bainbridge, Mark Buchfuhrer

Sleep Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
Daniel O Lee, Mark J Buchfuhrer, Diego Garcia-Borreguero, Alon Y Avidan, Mansoor Ahmed

Sleep Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
Richard K Bogan, Daniel O Lee, Mark J Buchfuhrer, Mark J Jaros, Richard Kim

Ann Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensory stimuli and the restless legs syndrome.
Fred Burbank, Mark J Buchfuhrer

J Clin Sleep Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for the treatment of restless legs syndrome.
Mark J Buchfuhrer

Neurotherapeutics· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadiness.
Mark J Buchfuhrer

Evid Based Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restless legs syndrome (RLS) with expansion of symptoms to the face.
Mark J Buchfuhrer

Sleep Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithm for the management of restless legs syndrome.
Michael H Silber, Bruce L Ehrenberg, Richard P Allen, Mark J Buchfuhrer, Christopher J Earley

Mayo Clin Proc· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis